missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Recombinant Human Kallikrein 14 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity

Brand:  R&D Systems™ 2626-SE-010

Product Code. 18329637

  • 591.00€ / 10µg
Estimated Shipment: 27-01-2025
to see stock.
Explore more special offers
Add to basket
This item is not returnable. View return policy

Description

Description

The Recombinant Human Kallikrein 14 Protein is derived from NS0. The Recombinant Human Kallikrein 14 Protein has been validated for the following applications: Enzyme Activity.
Specifications

Specifications

Supplied as a 0.2μm filtered solution in Tris, NaCl and Glycerol.
26 kDa
10 μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening.
Unconjugated
95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
43847
Kallikrein 14
Mouse myeloma cell line,NS0-derived human Kallikrein 14 protein Gln19-Met248,with a C-terminal 10-His tag
Pro form
Recombinant
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

One moment while we fetch your results.
Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title
R&D Systems™ Recombinant Human Kallikrein 14 Protein > 10ug; Carrier Free

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.